Consensus paper on ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research
Journals and pharma collaborate on new recommendations to close credibility gap in industry-sponsored research
- Date : 10 May 2012
- Topic : Basic science
The Medical Publishing Insights and Practices initiative and its co-sponsors recently collaborated with journal editors to characterize the persistent and perceived credibility gap in reporting industry-sponsored research and to identify potential approaches to resolve it. This unique round table reached consensus on ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research as reported in the May issue of Mayo Clinic Proceedings.
Attendees of the round table agreed that important improvements have been made in the conduct and reporting of industry-sponsored studies during the last five years, but several opportunities remain for additional improvement. These include ensuring that clinical studies and publications address clinically important questions; making public all results, including negative or unfavourable ones in a timely fashion, while avoiding redundancy; and exhibiting zero tolerance for selective or biased disclosure of research results, ghost-writing and guest authorship, and inaccurate or incomplete reporting of potential conflicts of interest.
The recommendations are more widely applicable to enhance the credibility of clinical research publications regardless of the funding source
Intended as a ”call to action” for all stakeholders, these recommendations provide a road map for authors, editors, and publishers to improve standards applicable to all medical research studies and publications by highlighting critical areas that merit attention in terms of policies, education, and other activities, according to Maja Zecevic, PhD, MPH, corresponding author of the paper and North American senior editor of The Lancet.
Although framed in the context of industry sponsorship, many of these recommendations are more widely applicable to enhance the credibility of clinical research publications in general, regardless of the funding source.
The Medical Publishing Insights and Practices initiative was founded in 2008 by members of the pharmaceutical industry and the International Society for Medical Publication Professionals to elevate trust, transparency, and integrity in publishing industry-sponsored studies. The initiative seeks to promote more effective partnership between sponsors and journals to raise standards in medical publishing and expand access to study results. To date, it has identified issues perceived by journals to be barriers to transparency and trust and collaborated with journal editors and publishers on actionable solutions and resources. The Medical Publishing Insights and Practices initiative is a collaboration co-sponsored by Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Merck, Pfizer, Takeda, and the International Society for Medical Publication Professionals.
Thank you for rating!
You have already rated this page, you can only rate it once!